118 results
Page 2 of 6
8-K
EX-99.1
x547l0
22 May 23
Results of Operations and Financial Condition
7:03am
424B5
koff1n 3a
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
6g1261rcah 10
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
8-K
EX-99.1
yqlpcftq1b5paa898yxd
8 Jun 22
Results of Operations and Financial Condition
7:05am
8-K
EX-10.1
xvt1d
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am
PRE 14A
159jc72vmhs
2 Aug 21
Preliminary proxy
4:31pm
8-K
EX-99.1
ny8bxi yt4pa
2 Aug 21
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
8:09am
8-K
EX-10.1
672vui rmbe
2 Aug 21
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
8:09am